AstraZeneca announces availability of Saxa / Dapa FDC in UK UK-based AstraZeneca has announced the availability of Qtern for adult patients with type 2 diabetes in the country. Quern is a fixed dos...
Payers block Kaléo's expensive EpiPen challenger Kaléo reintroduced its Auvi-Q last week at a list price of $4,500 for a two-pack in an effort to capture some market share from Mylan’s EpiPen, which is listed at about $600 for a two-pack. Auvi-Q is set to launch next month. Under Kaléo’s pricing strategy, Auvi-Q wil...
Find MoreWith Flublok at a standstill in Japan, Astellas ditches collaborator UMN Pharma After Japanese regulators turned away the partners’ submission for a new cell-culture flu vaccine, Astellas has pulled the plug on a collaboration with UMN Pharma. UMN said it’s “regrettable” the companies can no longer work together to ...
Find MoreThe high cost of pharmaceuticals, especially Biologics, has been proven as an issue in the battle to control healthcare costs. The Biologics Price Competition and the Innovation Act has put forward the generic competition of Biologics or what is popularly called the Biosimilars. Biosimilars have been available in th...
Find MoreSystemic Lupus Erythematosus (SLE) is a systemic autoimmune disease. The disease has a highly variable course and prognosis. The term lupus has been used to identify a number of chronic, autoimmune diseases that can damage any part of the body (such as skin, joints, and/or organs inside the body). Common symptoms in...
Find MoreChronic obstructive pulmonary disease (COPD) is a progressive life-threatening lung disease which leads to airflow limitation and interferes with normal breathing. According to World Health Organization, approximately 64 million people are affected by COPD worldwide. World Health Organization estimates Chronic Obstr...
Find MoreFor Inflectra launch, Pfizer uses 'hybrid model' to home in on HCPs Pfizer hit the market with Inflectra, a biosimilar of Johnson & Johnson's Remicade. And with the launch came not only the beginning of a new class of copycats, but a new way to go to market. Each biosimilar, even versions of the same biologic—wh...
Find MoreSjögren's syndrome was named on Henrik Sjögren who described this indication in 1933, and is a chronic autoimmune disease in which body’s own immune system and white blood cells attack moisture producing glands such as tear and salivary glands, leading to dry mouth and eyes. There are certain other symptoms involved...
Find More7 million people are living with HIV, 40% don’t know their status New HIV infections among children have declined by 50% since 2010. The incidence of HIV/AIDS is increasing among young gay men. UNAIDS released a report showing 18.2 million people are now on antiretroviral therapy. However, it found women ag...
Find MoreNovartis Buys Blood Disease Drug Maker for $665mn Novartis has acquired Selexys Pharmaceuticals, a drug maker specializing in development of therapeutics in certain hematologic and inflammatory disorders. Novartis exercised its right to acquire Selexys following receipt of results of the SUSTAIN study, a Phase II tr...
Find MoreAn autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....
Find MoreMedical device manufacturing and development is a high-capital demanding endeavor and therefore the .....
Find MoreRetinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye.....
Find MoreThe medical device industry is a dynamic, innovative, and heterogeneous sector. The MedTech industry.....
Find MoreAutoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfun.....
Find MoreIPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug .....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.